CJEU Ruling Clarifies Scope of 'Medical Device' Definition
The Court of Justice of the European Union has issued a new ruling on the definition of a medical device, a decision with significant compliance implications for manufacturers of software and other borderline products.
The Court of Justice of the European Union (CJEU) has issued a ruling clarifying the scope of the term “medical device” under the EU’s Medical Device Regulation (MDR). The definition is a critical gateway that determines whether a product is subject to the MDR's stringent requirements for clinical evidence, quality management systems, and post-market surveillance.
This decision is particularly important for manufacturers of “borderline” products, where regulatory status can be ambiguous. This includes many software products, such as wellness applications and clinical decision support tools, as well as certain cosmetic or aesthetic devices. A broad interpretation by the court could pull a wider range of products into this demanding regulatory regime, affecting development costs, timelines, and market access. Conversely, a narrow interpretation could provide greater certainty for developers innovating outside traditional healthcare hardware.
Affected companies and their counsel should promptly analyze the ruling to assess its impact on current and future product portfolios and determine whether changes to regulatory strategy are required.